Robert Goeltz II

Insider Reports History

Entity
Individual
Location
343 Oyster Point Blvd, Suite 100, South San Francisco, CA
Signature
/s/ Carolyn Tang, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Goeltz II:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Arcus Biosciences, Inc. Chief Financial Officer Common Stock 97.1K $1.46M $15.00 Jan 23, 2025 Direct
Arcus Biosciences, Inc. Chief Financial Officer Stock Option (right to buy) 150K Jan 23, 2025 Direct

Insider Reports Filed by Robert Goeltz II

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RCUS Arcus Biosciences, Inc. Jan 23, 2025 2 $0 4 Jan 27, 2025 Chief Financial Officer
RCUS Arcus Biosciences, Inc. Dec 31, 2024 1 -$53.9K 4 Jan 3, 2025 Chief Financial Officer
RCUS Arcus Biosciences, Inc. Dec 15, 2024 1 -$162K 4 Dec 17, 2024 Chief Financial Officer
RCUS Arcus Biosciences, Inc. Jan 23, 2024 1 $0 4/A Feb 23, 2024 Chief Financial Officer
RCUS Arcus Biosciences, Inc. Jan 23, 2024 2 $0 4 Jan 25, 2024 Chief Financial Officer
RCUS Arcus Biosciences, Inc. Jan 2, 2024 1 -$40.1K 4 Jan 4, 2024 Chief Financial Officer
RCUS Arcus Biosciences, Inc. Dec 18, 2023 2 -$99.6K 4 Dec 20, 2023 Chief Financial Officer
RCUS Arcus Biosciences, Inc. Jun 7, 2023 1 -$81.1K 4 Jun 9, 2023 Chief Financial Officer
RCUS Arcus Biosciences, Inc. Jan 23, 2023 2 $0 4 Jan 25, 2023 Chief Financial Officer
RCUS Arcus Biosciences, Inc. Dec 16, 2022 2 -$75.4K 4 Dec 16, 2022 Chief Financial Officer
RCUS Arcus Biosciences, Inc. Mar 8, 2022 2 $0 4 Mar 10, 2022 Chief Financial Officer
RCUS Arcus Biosciences, Inc. Dec 16, 2021 6 -$44.4K 4 Dec 20, 2021 Chief Financial Officer